Integration of PV with Regulatory Affairs, Clinical Research, and Quality

Pharmacovigilance does not operate in isolation. It sits at the intersection of clinical, regulatory, and quality functions — and effective safety management requires continuous collaboration across these domains. A PV team that operates as a silo, receiving and processing reports without engaging clinical, regulatory, or quality colleagues, will consistently miss context that changes the interpretation of safety data.

Regulatory Affairs handles label updates and SmPC variations, GVP/ICH compliance filing, regulatory query responses, and RMP submissions. Clinical Research handles protocol safety-endpoint design, informed-consent AE-reporting guidance, DSMB coordination, SUSAR reporting from trial sites, and DSUR authorship. Quality & Compliance handles SOP adherence, CAPA tracking, inspection preparation (PSMF), training records, and third-party PV vendor oversight. Pharmacovigilance functions as the integrating hub across all three, connected through cross-functional safety dashboards, E2B(R3) data exchange, and the signal-to-action pipeline.

Modern PV operations use dashboards that let a safety physician reviewing a new signal immediately see whether a recent label change in another market addressed a related risk, whether a PASS is already underway for the same concern, and whether recent manufacturing quality deviations might affect the product’s impurity profile. Under GVP Module I Rev 3 (2025), the QPPV’s oversight explicitly extends across all of these functions — not just the formal regulatory reporting channel — meaning the QPPV must be embedded in the organisation’s broader governance structure.

This is one of the more common blind spots for people new to PV: assuming the job is "process the case, submit the report" in isolation. In practice, a genuinely good drug safety associate is constantly asking whether a quality deviation, a protocol amendment, or a regulatory query from another market changes how the case in front of them should be read.